William Cavanagh - Net Worth and Insider Trading
William Cavanagh Net Worth
The estimated net worth of William Cavanagh is at least $27,718 dollars as of 2024-11-13. William Cavanagh is the Chief R&D Officer of Perspective Therapeutics Inc and owns about 2,769 shares of Perspective Therapeutics Inc (CATX) stock worth over $27,718. Details can be seen in William Cavanagh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Cavanagh has not made any transactions after 2020-10-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Cavanagh
William Cavanagh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Cavanagh owns 1 companies in total, including Perspective Therapeutics Inc (CATX) .
Click here to see the complete history of William Cavanagh’s form 4 insider trades.
Insider Ownership Summary of William Cavanagh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CATX | Perspective Therapeutics Inc | 2020-10-22 | Vice President |
William Cavanagh Latest Holdings Summary
William Cavanagh currently owns a total of 1 stock. William Cavanagh owns 2,769 shares of Perspective Therapeutics Inc (CATX) as of October 22, 2020, with a value of $27,718.
Latest Holdings of William Cavanagh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CATX | Perspective Therapeutics Inc | 2020-10-22 | 2,769 | 10.01 | 27,718 |
Holding Weightings of William Cavanagh
William Cavanagh Form 4 Trading Tracker
According to the SEC Form 4 filings, William Cavanagh has made a total of 2 transactions in Perspective Therapeutics Inc (CATX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Perspective Therapeutics Inc is the acquisition of 769 shares on October 22, 2020, which cost William Cavanagh around $4,000.
Insider Trading History of William Cavanagh
- 1
William Cavanagh Trading Performance
GuruFocus tracks the stock performance after each of William Cavanagh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Cavanagh is 206.84%. GuruFocus also compares William Cavanagh's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Cavanagh within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Cavanagh's insider trading performs compared to the benchmark.
Performance of William Cavanagh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 24.01 | | | | | |
| Relative Return to S&P 500(%) | 24.15 | | | | | |
William Cavanagh Ownership Network
Ownership Network List of William Cavanagh
Ownership Network Relation of William Cavanagh
William Cavanagh Owned Company Details
What does Perspective Therapeutics Inc do?
Who are the key executives at Perspective Therapeutics Inc?
William Cavanagh is the Vice President of Perspective Therapeutics Inc. Other key executives at Perspective Therapeutics Inc include Chief Financial Officer Jonathan Robert Hunt , Vice President Lori A Woods , and director & CEO Johan M. Spoor .
Perspective Therapeutics Inc (CATX) Insider Trades Summary
Over the past 18 months, William Cavanagh made no insider transaction in Perspective Therapeutics Inc (CATX). Other recent insider transactions involving Perspective Therapeutics Inc (CATX) include a net purchase of 427,455 shares made by Williamson Robert F Iii , a net purchase of 224,033 shares made by Lori A Woods , and a net purchase of 151,806 shares made by Jonathan Robert Hunt .
In summary, during the past 3 months, insiders sold 0 shares of Perspective Therapeutics Inc (CATX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Perspective Therapeutics Inc (CATX) were sold and 6,226,724 shares were bought by its insiders, resulting in a net purchase of 6,226,724 shares.
Perspective Therapeutics Inc (CATX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Perspective Therapeutics Inc Insider Transactions
William Cavanagh Mailing Address
Above is the net worth, insider trading, and ownership report for William Cavanagh. You might contact William Cavanagh via mailing address: 350 Hills Street, Suite 106, Richland Wa 99354.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
